Emmanouil Karteris

London, ENG UB83PH, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

Integrative In Silico mRNA-miRNA Profiling of mTOR Pathway Dysregulation in High-Grade Serous Ovarian Carcinoma.

Integrative In Silico mRNA-miRNA Profiling of mTOR Pathway Dysregulation in High-Grade Serous Ovarian Carcinoma.

Journal: Cancers
Published: January 31, 2026

Investigating the contribution of circulating inflammatory cytokines on the link between obesity and COVID-19.

Investigating the contribution of circulating inflammatory cytokines on the link between obesity and COVID-19.

Journal: Adipocyte
Published: December 08, 2025

Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer.

Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer.

Journal: Molecules (Basel, Switzerland)
Published: June 30, 2025

Evaluating plasma adipokines and their cognate receptors as biomarkers for non-invasive diagnosis of endometrial cancer.

Evaluating plasma adipokines and their cognate receptors as biomarkers for non-invasive diagnosis of endometrial cancer.

Journal: Bioscience reports
Published: April 28, 2025

Asprosin activates multiple placental pathways in vitro: Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways.

Asprosin activates multiple placental pathways in vitro: Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways.

Journal: Molecular medicine reports
Published: February 14, 2025

The Association Between Metabolic Syndrome and the Risk of Endometrial Cancer in Pre- and Post-Menopausal Women: A UK Biobank Study.

The Association Between Metabolic Syndrome and the Risk of Endometrial Cancer in Pre- and Post-Menopausal Women: A UK Biobank Study.

Journal: Journal of clinical medicine
Published: December 04, 2024

Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer.

Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer.

Journal: Scientific reports
Published: November 01, 2024

Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review.

Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review.

Journal: Expert review of endocrinology & metabolism
Published: June 11, 2024

The "Road" to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review.

The "Road" to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review.

Journal: Cancers
Published: April 19, 2024

Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model.

Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model.

Journal: Anticancer research
Published: January 23, 2024

In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma.

In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma.

Journal: Cancers
Published: December 29, 2023

SV2B/miR-34a/miR-128 axis as prognostic biomarker in glioblastoma multiforme.

SV2B/miR-34a/miR-128 axis as prognostic biomarker in glioblastoma multiforme.

Journal: Scientific reports
Published: November 23, 2023
Showing 1-12 of 81

Last Updated: 09/26/2026